A Tool to Improve Evaluation of Patient Navigation Services in Underserved Populations

美国原住民癌症倡议公司(NACI)是一家由女性拥有的少数族裔(美国印第安人)企业 拥有不到三名相当于全职员工的员工。这家营利性公司成立于1998年，拥有 提供美洲原住民技术援助和产品的使命，文化问题，评估， 整个过程中的方案制定和评估以及癌症护理(通过临终关怀进行推广 护理)社区、患者、医疗保健提供者、研究人员、院士、大学、研究人员 机构和其他专业人士。此阶段SBIR的目标是扩展和增强当前的 第一阶段患者导航评估应用程序，用于开发、实施和评估易于使用、功能齐全的应用程序 针对整个癌症连续体的应用程序，可以根据个别患者的需求进行定制 导航程序，可用于多种操作和电子健康记录(EHR)系统。那里 这款应用程序将有两个版本：一个是iOS(IPad)，另一个是Android(三星、联想、LG和 Nexus)。在第三阶段，该应用程序将针对Windows操作系统进行扩展。目标1.制定一项 扩展的应用程序在iOS中整合了癌症连续体的所有阶段(通过生命末期进行扩展) 编程，并可以为个人导航程序量身定做。目标1成果：功能强大的平板电脑应用 用于记录PN行动的完整癌症连续体(组件1)，并可生成定制的报告以 评估个人和团队的PNS(组件2)和评估患者导航计划(组件2 3)。目标2.开发、实施和评估(A)应用程序教程(硬拷贝和视频)，(B)应用程序用户指南，以及 (C)网站和电话支持协议和方案。目标2结果：4-5分钟的YouTube和Hard 副本、应用程序教程、全面的应用程序用户指南、包含解决常见问题的信息的支持网页 问题，还有一条电话求助热线。目标3.修改iOS应用程序以在Android平板电脑上使用，并将两者集成 至少有一个电子病历系统的应用程序。目标3成果：安卓平板电脑上可用的应用程序，协议 将APP数据与一个EHR系统(如EPIC)对接，并将功能APP数据与 啊哈。这些结果的影响将成为促进PN和导航计划合规性的工具 标准化指标和癌症委员会对患者导航的要求。功能齐全的应用 将涉及整个癌症连续体，但可以针对单个导航计划(例如，一个或 更多的连续阶段(如预防或临终)或癌症类型(乳腺癌或肺癌)。会是 适用于使用iOS(IPad)和Android操作系统的平板电脑。在第二阶段完成后，这些应用程序将 准备好通过指定的商业化计划进行推广。患者导航计划需要 全面的评估协议和工具，可以评估PN和计划的质量和有效性。 根据广泛的文献和互联网评论，目前几乎没有一个是易于使用、高效和 在平板电脑上运行，没有一款应用程序像为第二阶段SBIR建议的应用程序那样全面。

Native American Cancer Initiatives, Inc. (NACI) is a woman-owned, minority (American Indian) business with fewer than three full-time-equivalent employees. This for-profit company, founded in 1998, has the mission to provide technical assistance and products on Native Americans, cultural issues, evaluation, program development and assessment and cancer care across the continuum (outreach through end-of-life care) to communities, patients, healthcare providers, researchers, academicians, universities, research institutions, and other professionals. The goal for this Phase II SBIR is to expand and enhance the current Phase I patient navigation evaluation app to develop, implement and evaluate an easy-to-use, fully functioning app that addresses the full cancer continuum, can be tailored to meet the needs of an individual patient navigation program and is available for multiple operating and Electronic Health Record (EHR) systems. There will be two versions of the app: one for iOS (iPad) and the other for Android (Samsung, Lenovo, LG and Nexus). During Phase III the app will be expanded for Windows operating systems. Aim 1. Develop an expanded app that incorporates all phases of the cancer continuum (outreach through end-of-life) in iOS programming and can be tailored for an individual navigation program. Aim 1 Outcomes: Functional tablet app for the full cancer continuum that documents PN Actions (component 1) and can generate tailored reports to evaluate individual and groups of PNs (component 2) and evaluate patient navigation programs (component 3). Aim 2. Develop, implement and evaluate (a) an app tutorial (hard copy and video), (b) app user guide, and (c) a website and phone support protocol and program. Aim 2 Outcomes: a 4-5-minute YouTube and hard copy, app tutorial, a comprehensive app user guide, a support webpage with information to address common problems, and a telephone helpline. Aim 3. Modify the iOS app for use with Android tablets and integrate both apps with at least one EHR system. Aim 3 Outcomes: app available on Android tablets, a protocol for interfacing app data with one EHR system (e.g., Epic) and the interface of the functional app data with the EHR. The impact of these outcomes will be a tool that facilitates PN and navigation program compliance with standardized metrics and Commission on Cancer requirements for patient navigation. The fully functional app will address the entire cancer continuum but can be tailored to an individual navigation program (e.g., one or more phases of the continuum (e.g., prevention or end-of-life) or types of cancer (breast or lung). It will be available for tablets using iOS (iPad) and Android operating systems. At completion of Phase II, the apps will be ready to be promoted via the designated commercialization plan. Patient navigation programs need comprehensive evaluation protocols and tools that can assess both PN and program quality and effectiveness. Based on extensive literature and Internet review, currently almost none are easy-to-use, efficient and functional on tablets and none are as comprehensive as the apps proposed for this Phase II SBIR.